Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WANBURY vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WANBURY   ACTAVIS
EQUITY SHARE DATA
    WANBURY
Mar-23
ACTAVIS
Dec-18
WANBURY/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs9016,126-   
Low Rs3310,818-   
Sales per share (Unadj.) Rs152.83,955.8-  
Earnings per share (Unadj.) Rs-3.2-1,274.2-  
Cash flow per share (Unadj.) Rs0.6416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-10.516,315.7-  
Shares outstanding (eoy) m32.71332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.43.4 11.8%   
Avg P/E ratio x-19.3-10.6 182.3%  
P/CF ratio (eoy) x100.832.3 311.8%  
Price / Book Value ratio x-5.80.8 -704.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,0044,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m8100-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m4,9961,315,689 0.4%  
Other income Rs m1025,160 0.0%   
Total revenues Rs m5,0071,340,849 0.4%   
Gross profit Rs m22534,478 0.7%  
Depreciation Rs m124562,428 0.0%   
Interest Rs m21475,923 0.3%   
Profit before tax Rs m-103-578,713 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m1-7,334 -0.0%   
Profit after tax Rs m-104-423,784 0.0%  
Gross profit margin %4.52.6 171.7%  
Effective tax rate %-1.11.3 -83.6%   
Net profit margin %-2.1-32.2 6.5%  
BALANCE SHEET DATA
Current assets Rs m1,222539,627 0.2%   
Current liabilities Rs m3,204477,372 0.7%   
Net working cap to sales %-39.74.7 -838.4%  
Current ratio x0.41.1 33.7%  
Inventory Days Days420 20.6%  
Debtors Days Days49766 748.9%  
Net fixed assets Rs m1,742148,929 1.2%   
Share capital Rs m3270-   
"Free" reserves Rs m-6720-   
Net worth Rs m-3445,426,601 -0.0%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m2,9848,483,012 0.0%  
Interest coverage x0.5-6.6 -7.8%   
Debt to equity ratio x00.4 -0.0%  
Sales to assets ratio x1.70.2 1,079.7%   
Return on assets %3.7-4.1 -89.9%  
Return on equity %30.2-7.8 -386.4%  
Return on capital %-32.2-4.8 666.1%  
Exports to sales %58.00-   
Imports to sales %20.50-   
Net fx Rs m1,9250-   
CASH FLOW
From Operations Rs m198470,046 0.0%  
From Investments Rs m-88258,229 -0.0%  
From Financial Activity Rs m-320-806,740 0.0%  
Net Cashflow Rs m-210-78,073 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare WANBURY With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WANBURY With: GUJ.TERC LAB  BLISS GVS PHARMA  ZANDU REALTY  DENIS CHEM LAB  ADLINE CHEM LAB  



Today's Market

Tech Mahindra Q4 Results | ACC Declares Interim Dividend | Top Buzzing Stocks Today Tech Mahindra Q4 Results | ACC Declares Interim Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended the higher.